1. Home
  2. MYGN vs SIMO Comparison

MYGN vs SIMO Comparison

Compare MYGN & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYGN
  • SIMO
  • Stock Information
  • Founded
  • MYGN 1991
  • SIMO 1995
  • Country
  • MYGN United States
  • SIMO Hong Kong
  • Employees
  • MYGN N/A
  • SIMO N/A
  • Industry
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SIMO Semiconductors
  • Sector
  • MYGN Health Care
  • SIMO Technology
  • Exchange
  • MYGN Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • MYGN 2.0B
  • SIMO 1.9B
  • IPO Year
  • MYGN 1995
  • SIMO 2005
  • Fundamental
  • Price
  • MYGN $15.25
  • SIMO $51.55
  • Analyst Decision
  • MYGN Buy
  • SIMO Strong Buy
  • Analyst Count
  • MYGN 12
  • SIMO 9
  • Target Price
  • MYGN $27.64
  • SIMO $81.67
  • AVG Volume (30 Days)
  • MYGN 990.7K
  • SIMO 253.0K
  • Earning Date
  • MYGN 11-07-2024
  • SIMO 10-30-2024
  • Dividend Yield
  • MYGN N/A
  • SIMO 3.91%
  • EPS Growth
  • MYGN N/A
  • SIMO 58.68
  • EPS
  • MYGN N/A
  • SIMO 2.64
  • Revenue
  • MYGN $823,600,000.00
  • SIMO $814,771,000.00
  • Revenue This Year
  • MYGN $13.85
  • SIMO $29.10
  • Revenue Next Year
  • MYGN $7.73
  • SIMO $6.02
  • P/E Ratio
  • MYGN N/A
  • SIMO $19.40
  • Revenue Growth
  • MYGN 12.15
  • SIMO 27.80
  • 52 Week Low
  • MYGN $15.18
  • SIMO $50.50
  • 52 Week High
  • MYGN $29.30
  • SIMO $85.87
  • Technical
  • Relative Strength Index (RSI)
  • MYGN 16.18
  • SIMO 44.04
  • Support Level
  • MYGN $16.86
  • SIMO $50.50
  • Resistance Level
  • MYGN $19.60
  • SIMO $54.16
  • Average True Range (ATR)
  • MYGN 1.17
  • SIMO 2.02
  • MACD
  • MYGN -0.25
  • SIMO 0.01
  • Stochastic Oscillator
  • MYGN 0.90
  • SIMO 40.19

About MYGN Myriad Genetics Inc.

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is active in the semiconductor industry and focuses on designing, developing, and marketing of controllers for managing NAND flash used in embedded storage applications, such as eMMC embedded memory. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: